WHO ICTRP trial
A Study to Evaluate the Safety of Brivaracetam to be given by Intravenous…
EUCTR2008-004714-27-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-004714-27-CZ |
|---|---|
| Public title | A Study to Evaluate the Safety of Brivaracetam to be given by Intravenous Infusion in Subjects Aged Between 16 to 70 years Suffering from Epilepsy |
| Scientific title | A Multicenter, Open-label, Four-arm, Randomized trial, Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects from 16 to 70 years Suffering from Epilepsy. |
| Primary sponsor | UCB Biosciences, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United States;Czech Republic;Germany;United States;Czech Republic;Germany |
| Conditions | Epilepsy MedDRA version: 14.1 Level: PT Classification code 10015037 Term: Epilepsy System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10];Epilepsy MedDRA version: 14.1 Level… |
| Interventions | Product Name: brivaracetam Product Code: ucb 34714 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: BRIVARACETAM CAS Number: 357336-20-0 Current Sponsor code: ucb 34714 Other descriptive name… |
| Registration date | Dec 1, 2009 |
| Target size | 125 |
| Secondary IDs | N01258;N01258 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: